Category Archives: Cardiovascular

Deferred testing for low-risk chest pain patients is safe, limits unnecessary catheterizations

Among patients who had their testing deferred, 64% never underwent testing over the study’s follow-up period of one year. The remaining 36% eventually underwent downstream testing after a median time period of 48 days “based on ongoing or worsening symptoms.” Results were completely normal for 96% of patients when they did undergo testing. For patients […]

Texas researchers receive $1.14M to develop first CVD drug of its kind

The Texas Heart Institute (THI) in Houston, recently ranked one of the top 20 U.S. hospitals for cardiology and heart surgery, has received a two-year grant worth $1.14 million to develop a first-in-class drug capable of limiting inflammation and reducing a patient’s risk of cardiovascular disease (CVD). The grant came from the National Heart, Lung […]

Boehringer Ingelheim’s Elena Livshina Finds Purpose in Tackling Cardiovascular Inequities

The company’s US head for the cardiovascular portfolio is leading the effort to find new treatments for women living with heart disease, especially those in underserved populations. Elena Livshina came to the cardiac space by falling in love. Not with a person, but through a new discovery. Back in 2016, the US head of the […]

ESC statement: Competency-based cardiac imaging delivery needed for effective patient care

Competency-based cardiac imaging delivery is needed for effective and efficient patient care, according to a European Society of Cardiology (ESC) statement published today in European Heart Journal, a journal of the ESC. All seven ESC subspeciality associations have endorsed the document, namely the European Association of Cardiovascular Imaging (EACVI), Association of Cardiovascular Nursing & Allied […]

PLMS Are Another Risk Factor for Cardiovascular Disease in OSA, Study Suggests

Periodic limb movements during sleep (PLMS) are an additional risk factor for cardiovascular disease in obstructive sleep apnea (OSA), according to a study published in Journal of Sleep Research. PLMS and OSA are both linked with increased sympathetic tone and have been proposed as risk factors for heart diseases, including cardiovascular disease in particular, the […]

New ESC Guidelines for the management of cardiovascular disease in patients with diabetes released

Patients with type 2 diabetes are more than twice as likely to develop cardiovascular disease (CVD) than their healthy peers. Advice to lower that risk is launched today in the 2023 European Society of Cardiology (ESC) Guidelines for the management of cardiovascular disease in patients with diabetes, published in European Heart Journal. Patients with type […]

Weight loss drug semaglutide linked to multiple benefits for heart failure patients

The median patient age was 69 years old, median body weight was 105.1 kg and median body mass index was 37.0 kg/m2. Patients came from 13 different countries throughout North America, South America, Europe and Asia. A Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS) was calculated for each participant at the beginning and end […]

Cardio or cerebrovascular mortality of AF patients has declined in the UK over 16 years

Patients living with one of the UK’s most common heart rhythm conditions are 50% less likely to die from a heart attack or stroke than they were at the start of the millennium, new research has found. Analysis of the health records of more than 70,000 patients newly diagnosed with atrial fibrillation (AF) showed that […]

New weight-loss drug Wegovy has major heart benefits, too

Many people with obesity also have heart disease, and the latest research confirms that new weight-loss medications may help with both. Trial subjects with both obesity and a condition called heart failure with preserved ejection fraction saw significant benefit from taking the drug semaglutide for a year, a Friday study in the New England Journal […]